CD4+ cell count increase was lower in HCV patients (+23 vs +86 at 6 month; p=0.02).<h4>Conclusions</h4>Etravirine is safe in HIV/HCV coinfected patients, even in presence of moderate and advanced liver fibrosis and as part of different antiretroviral regimens. This evidence concerns the gene CD4 and Hepatic fibrosis.